secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0000950170-24-092780
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q2 revenue $27.4M (-24% YoY); FY2024 guidance cut to ~$110M from $145-153M
--------------------------------------------------------------------------------

- Product revenue fell to $19.2M; service revenue rose 21.5% to $8.2M.
- GAAP net loss $(0.66)/share; non-GAAP net loss $(0.47)/share.
- Total gross margin improved to 35.7% from 21.4% YoY; non-GAAP gross margin 37.3%.
- FY2024 revenue guidance revised to ~$110M (prior $145-153M); non-GAAP gross margin now low-to-mid 30%.
- New console placements below expectations; company taking steps to improve execution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/0000950170-24-092780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/om-20240807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-092780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer